So Anvisa gave LL clearance for CD17 on Aug 3, about 10 days after it was cleared by the ethics committee. But to the best of knowledge CD 19 still has not received clearance from Anvisa though I saw the news about its being approved by the ethics committee. This suggests to me that the Brazil problem may be bigger than the customs. Did Nader tell us all we need to know in his last video?
(1)
(3)
CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.